• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腔内后装放疗——44例患者的初步临床报告]

[Intracavitary afterloading radiotherapy--preliminary clinical report on 44 patients].

作者信息

Sun J H, Zhang W H, Li A L, Liu C M

出版信息

Zhonghua Zhong Liu Za Zhi. 1987 Jan;9(1):53-5.

PMID:3595427
Abstract

This report describes the 2 year results of the treatment of 44 patients (1 vaginal carcinoma, 3 endometrial carcinoma and 40 cervical carcinoma) by Buchler afterloading equipment. One patient with vaginal carcinoma and two with endometrial carcinoma are live without disease over 2 years. There were 40 patients with cervical carcinoma: 1 stage I, 21 stage II (52.8%) and 18 stage III (45%). The dose-rate of the source is 10-25 cGy/min. A total dose of 41-55 Gy was given at point A in 87.5% of cases. The measurement of the bladder and the rectum were made in all the 40 patients during the treatment. The dose at the bladder was less than 30 Gy and only 10% of patients had a dose of over 30 Gy at the rectum. A dose of 40-45 Gy external irradiation by 8MV X-rays was delivered to the parametrium in each patient. One died of cancer, 2 were lost in follow up and 3 had local recurrence and metastasis. The two year survival rate was 92.5%. Only 4 had mild rectal reactions during the treatment and 2 had mild rectal bleeding after treatment.

摘要

本报告描述了使用布勒后装设备对44例患者(1例阴道癌、3例子宫内膜癌和40例宫颈癌)进行治疗的2年结果。1例阴道癌患者和2例子宫内膜癌患者存活且无疾病超过2年。有40例宫颈癌患者:1例I期、21例II期(52.8%)和18例III期(45%)。源的剂量率为10 - 25 cGy/分钟。87.5%的病例在A点给予的总剂量为41 - 55 Gy。在所有40例患者的治疗过程中对膀胱和直肠进行了测量。膀胱接受的剂量小于30 Gy,只有10%的患者直肠接受的剂量超过30 Gy。每位患者均接受了8MV X射线对子宫旁组织40 - 45 Gy的外照射。1例死于癌症,2例失访,3例出现局部复发和转移。两年生存率为92.5%。治疗期间只有4例有轻度直肠反应,治疗后有2例有轻度直肠出血。

相似文献

1
[Intracavitary afterloading radiotherapy--preliminary clinical report on 44 patients].[腔内后装放疗——44例患者的初步临床报告]
Zhonghua Zhong Liu Za Zhi. 1987 Jan;9(1):53-5.
2
[Afterloading technique for carcinoma of the uterine cervix].[子宫颈癌的后装技术]
Zhonghua Zhong Liu Za Zhi. 1989 May;11(3):211-2.
3
Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.宫颈癌统一外照射放疗和高剂量率近距离放疗后晚期并发症的剂量学分析参考点比较研究
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):663-71. doi: 10.1016/j.ijrobp.2004.05.028.
4
[Outcome and complications of treatment by intracavitary afterloading radiotherapy in 143 patients with cervical cancer].[143例宫颈癌患者腔内后装放疗的治疗结果及并发症]
Zhonghua Fu Chan Ke Za Zhi. 1993 Nov;28(11):646-8, 699.
5
[External and intracavitary afterloading radiotherapy of cervical cancer: a report of 110 cases].[宫颈癌体外及腔内后装放射治疗:110例报告]
Zhonghua Fu Chan Ke Za Zhi. 1993 Nov;28(11):651-2, 699-700.
6
[Five years' experience on intracavitary afterloading technique for carcinoma of the uterine cervix].[子宫颈癌腔内后装技术的五年经验]
Zhonghua Zhong Liu Za Zhi. 1992 May;14(3):225-7.
7
High-dose-rate brachytherapy in uterine cervical carcinoma.子宫颈癌的高剂量率近距离放射治疗
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):125-30. doi: 10.1016/j.ijrobp.2004.09.017.
8
Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases.子宫颈癌初次放疗后晚期复发性阴道恶性肿瘤的治疗:73例分析
Gynecol Oncol. 1998 May;69(2):125-9. doi: 10.1006/gyno.1998.4975.
9
High-dose-rate interstitial brachytherapy for gynecologic malignancies.高剂量率组织间近距离治疗在妇科恶性肿瘤中的应用
Brachytherapy. 2006 Oct-Dec;5(4):218-22. doi: 10.1016/j.brachy.2006.09.002.
10
Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.低剂量率与高剂量率近距离放射治疗子宫颈癌的比较。两个连续系列的回顾性分析。
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1108-16. doi: 10.1016/j.ijrobp.2004.12.016.